• FirefoxTry Yahoo Finance on Firefox »
  •  Dow Up 2.00% Nasdaq Up 1.66%

    Impax Laboratories Inc. (IPXL)

    -NasdaqGS
    30.89 Up 0.16(0.52%) Feb 12, 4:00PM EST
    |After Hours : 30.90 Up 0.01 (0.02%) Feb 12, 5:07PM EST
    Prev Close:30.73
    Open:30.98
    Bid:N/A
    Ask:45.20 x 500
    1y Target Est:47.15
    Beta:1.15058
    Next Earnings Date:22-Feb-16IPXL Earnings announcement
    Day's Range:30.17 - 31.13
    52wk Range:30.17 - 52.10
    Volume:580,590
    Avg Vol (3m):668,890
    Market Cap:2.18B
    P/E (ttm):80.44
    EPS (ttm):0.38
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for IPXL

    Comparison

    Symbol% ChgMkt Cap
    IPXLUp 0.52%2.18B
    MYLUp 0.98%20.57B

    Key Statistics

    Forward P/E (1 yr):13.67
    P/S (ttm):3.04
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-15) :1.27
    Quarterly EPS Est (Dec-15) :0.44
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.71

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Impax Laboratories, Inc., a specialty pharmaceutical company, develops, manufactures, and markets bioequivalent pharmaceutical products. It operates in two segments, Global Pharmaceuticals Division and Impax Pharmaceuticals Division. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback